Neoplasm.News

Anti-PD-1 × Endocrine × Clear all

2 Announcements

FDA grants accelerated approval to dostarlimab-gxly for dMMR advanced solid tumors

Trial: GARNET
Drug: Jemperli (dostarlimab-gxly) · Anti-PD-1 antibody
Condition: Other solid neoplasm

FDA approves pembrolizumab for adults and children with TMB-H solid tumors

Trial: KEYNOTE 158
Drug: KEYTRUDA (pembrolizumab) · Anti-PD-1 antibody
Condition: Other solid neoplasm